|
These interviews, presentations, and panel discussions took place at the BPI Theater at BIO 2022 in San Diego, California. Centering the presentations around two key themes — emerging therapies and technologies — enabled theater speakers and attendees to engage complex, interconnected topics that are of interest to BPI readers. Speakers highlighted how their companies are responding to both challenges and opportunities relating to speed to market and manufacturing capacity, particularly where it concerns expressing and mass-producing novel proteins. Many presenters shared novel technologies that enable cell and gene therapy manufacturing, and product discovery and development innovations.
Dan Stanton, editor in chief of BioProcess Insider was on site, and his interviews with leading biopharmaceutical executives are also featured below.
Watch the full presentations by following the links below.
|
